225 related articles for article (PubMed ID: 12740574)
1. Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling.
Rui L; Vinuesa CG; Blasioli J; Goodnow CC
Nat Immunol; 2003 Jun; 4(6):594-600. PubMed ID: 12740574
[TBL] [Abstract][Full Text] [Related]
2. A role for Toll in autoimmunity.
Krieg AM
Nat Immunol; 2002 May; 3(5):423-4. PubMed ID: 11976718
[No Abstract] [Full Text] [Related]
3. CpG DNA stimulates autoreactive immature B cells in the bone marrow.
Azulay-Debby H; Edry E; Melamed D
Eur J Immunol; 2007 Jun; 37(6):1463-75. PubMed ID: 17474151
[TBL] [Abstract][Full Text] [Related]
4. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
Brummel R; Roberts TL; Stacey KJ; Lenert P
Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
[TBL] [Abstract][Full Text] [Related]
5. Enhancement and suppression of signaling by the conserved tail of IgG memory-type B cell antigen receptors.
Horikawa K; Martin SW; Pogue SL; Silver K; Peng K; Takatsu K; Goodnow CC
J Exp Med; 2007 Apr; 204(4):759-69. PubMed ID: 17420266
[TBL] [Abstract][Full Text] [Related]
6. Bacterial DNA induced iNOS expression through MyD88-p38 MAP kinase in mouse primary cultured glial cells.
Hosoi T; Suzuki S; Nomura J; Ono A; Okuma Y; Akira S; Nomura Y
Brain Res Mol Brain Res; 2004 May; 124(2):159-64. PubMed ID: 15135224
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.
Kandimalla ER; Bhagat L; Li Y; Yu D; Wang D; Cong YP; Song SS; Tang JX; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2005 May; 102(19):6925-30. PubMed ID: 15860583
[TBL] [Abstract][Full Text] [Related]
8. CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells.
Liu N; Ohnishi N; Ni L; Akira S; Bacon KB
Nat Immunol; 2003 Jul; 4(7):687-93. PubMed ID: 12766768
[TBL] [Abstract][Full Text] [Related]
9. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus.
Nakano S; Morimoto S; Suzuki J; Nozawa K; Amano H; Tokano Y; Takasaki Y
Rheumatology (Oxford); 2008 Feb; 47(2):145-9. PubMed ID: 18160420
[TBL] [Abstract][Full Text] [Related]
10. TLR9 signals after translocating from the ER to CpG DNA in the lysosome.
Latz E; Schoenemeyer A; Visintin A; Fitzgerald KA; Monks BG; Knetter CF; Lien E; Nilsen NJ; Espevik T; Golenbock DT
Nat Immunol; 2004 Feb; 5(2):190-8. PubMed ID: 14716310
[TBL] [Abstract][Full Text] [Related]
11. CD22: a multifunctional receptor that regulates B lymphocyte survival and signal transduction.
Tedder TF; Poe JC; Haas KM
Adv Immunol; 2005; 88():1-50. PubMed ID: 16227086
[TBL] [Abstract][Full Text] [Related]
12. Signaling in B cells via Toll-like receptors.
Peng SL
Curr Opin Immunol; 2005 Jun; 17(3):230-6. PubMed ID: 15886111
[TBL] [Abstract][Full Text] [Related]
13. Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
Vollmer J; Weeratna RD; Jurk M; Davis HL; Schetter C; Wüllner M; Wader T; Liu M; Kritzler A; Krieg AM
J Leukoc Biol; 2004 Sep; 76(3):585-93. PubMed ID: 15218053
[TBL] [Abstract][Full Text] [Related]
14. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells.
Patole PS; Gröne HJ; Segerer S; Ciubar R; Belemezova E; Henger A; Kretzler M; Schlöndorff D; Anders HJ
J Am Soc Nephrol; 2005 May; 16(5):1326-38. PubMed ID: 15772251
[TBL] [Abstract][Full Text] [Related]
15. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.
Babiuk S; Mookherjee N; Pontarollo R; Griebel P; van Drunen Littel-van den Hurk S; Hecker R; Babiuk L
Immunology; 2004 Sep; 113(1):114-20. PubMed ID: 15312142
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
17. Viral 5'-triphosphate RNA and non-CpG DNA aggravate autoimmunity and lupus nephritis via distinct TLR-independent immune responses.
Allam R; Pawar RD; Kulkarni OP; Hornung V; Hartmann G; Segerer S; Akira S; Endres S; Anders HJ
Eur J Immunol; 2008 Dec; 38(12):3487-98. PubMed ID: 19009528
[TBL] [Abstract][Full Text] [Related]
18. Heat shock up-regulates TLR9 expression in human B cells through activation of ERK and NF-kappaB signal pathways.
Chen W; Wang J; An H; Zhou J; Zhang L; Cao X
Immunol Lett; 2005 Apr; 98(1):153-9. PubMed ID: 15790521
[TBL] [Abstract][Full Text] [Related]
19. CD40-dependent and -independent activation of human tonsil B cells by CpG oligodeoxynucleotides.
Gantner F; Hermann P; Nakashima K; Matsukawa S; Sakai K; Bacon KB
Eur J Immunol; 2003 Jun; 33(6):1576-85. PubMed ID: 12778475
[TBL] [Abstract][Full Text] [Related]
20. Induction of autoantibody production but not autoimmune disease in HEL transgenic mice vaccinated with HEL in combination with CpG or control oligodeoxynucleotides.
Wang Y; Krieg AM
Vaccine; 2004 Jun; 22(20):2641-50. PubMed ID: 15193390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]